Genesis Healthcare Inc. Financials

Market Capitalization $16.94 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.77
Forward PE	11.22
Price to Sales TTM	$4.39
Price to Book MRQ	$8.07
Enterprise to Revenue	6.42
Enterprise to EBITDA	13.70

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2024-03-29
Most Recent Quarter	2024-09-30
Profit Margin	16.15%
Operating Margin	41.58%
Return on Assets TTM	6.24%
Return on Equity TTM	27.66%

Income Statement

Revenue TTM	$3,863,000,064
Revenue per Share TTM	$6.17
Quarterly Revenue Growth	3.10%
Gross Profit TTM	$3,107,000,064
EBITDA	$2,061,000,000
Net Income to Common TTM	$624,000,000
Diluted EPS TTM	$0.99
Quarterly Earnings Growth YoY	9.50%

Balance Sheet

Total Cash MRQ	$737,000,000
Total Cash per Share MRQ	$1.20
Total Debt MRQ	$
Total Debt to Equity MRQ	409.34
Current Ratio MRQ	0.32
Book Value per Share MRQ	$3.41

Cash Flow

Operating Cash Flow TTM	$2,135,000,064
Levered Free Cash Flow TTM	$1,277,500,032

GEN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	616,296,000
Float Shares	558,398,782
Avg 10 Volume	2,927,940
Avg 30 Volume	None
Shares Short	11,370,742
Short Ratio	3.12
Short % of Shares	2.40%
% Held by Insiders	9.24%
% Held by Institutions	86.42%

Stock Price Summary

Beta	1.05
Fifty Two Week Low	$19.08
Fifty Two Week High	$31.72
Fifty Two Week Change	11.88%
Day 50 MA	$28.95
Day 200 MA	$25.98

Dividends and Splits

Forward Annual Dividend Rate	$0.50
Forward Annual Dividend Yield	1.82%
Trailing Annual Dividend Rate	$0.50
Trailing Annual Dividend Yield	1.82%
Payout Ratio	50.51%
Dividend Date	2024-12-11
Ex Dividend Date	2024-11-18
Last Split Factor
Last Split Date	2004-12-01